Clinical Trials Logo

Clinical Trial Summary

The dissolution and absorption of oral drugs in the gastrointestinal tract is a complex process, which is affected by physiological factors such as transporters, metabolic enzymes, gene phenotypes, gastrointestinal diseases, intestinal flora and so on. Therefore, the investigators are planning to collect gastrointestinal mucosa tissues, gastric juice, saliva , feces and blood samples to investigate (1) the activity and abundance of metabolism enzymes/transports in different section of gastrointestinal tract, (2) the composition and physicochemical properties of gastric juice; (3) the distribution and abundance of bacterial in gastrointestinal mucosa, saliva, gastric juice and feces; (4) the composition and content of bile acid in gastrointestinal mucosa, gastric juice and plasma in Chinese volunteers who planning to undergo digestive endoscopy.


Clinical Trial Description

This is a single-center, open-labelled study. Twenty four Chinese adult volunteers who schedule for gastrointestinal endoscopy will be enrolled and will be not allowed to take products containing grapefruit, fruit juice, tea, coffee, wine and other foods or drinks containing caffeine, xanthine and alcohols at least 14 days before the gastrointestinal endoscopes. In addition, smoking is also prohibited. Screen will be performed any day between 3 and 14 days prior to the gastrointestinal endoscopes. Feces, saliva and 4 ml whole blood samples will be collected from these participants 3 days before gastrointestinal endoscopes for the detection of bacterial diversity, metabolic enzymes, transporter-related genotypes and bile acids. Afterwards, participants will undergo painless gastroscopy. Meanwhile, gastric juice, mucosal tissue from stomach, duodenum, jejunum, ileum, colon will be collected. The total number of mucosal tissue no more than 10. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04743726
Study type Observational [Patient Registry]
Source Peking University Third Hospital
Contact
Status Active, not recruiting
Phase
Start date October 31, 2020
Completion date September 2022

See also
  Status Clinical Trial Phase
Terminated NCT00341523 - Early Detection of Esophageal Cancer
Not yet recruiting NCT06419543 - Paradoxical Reactions of Remimazolam in Pediatric Painless Gastrointestinal Endoscopy
Not yet recruiting NCT05851885 - Evaluation of the Clinical Effectiveness of Upper Gastrointestinal Endoscopy Reporting System N/A
Completed NCT03724565 - Air Quality Check in Gastrointestinal Endoscopy Unit
Completed NCT02472730 - Cap Assisted Colonoscopy Enhances Quality Based Competency in Colonoscopy Among Trainees N/A
Recruiting NCT06218017 - Development of an Algorithm to Denoise HFNO-generated Tracheal Sound N/A
Recruiting NCT05851716 - Upper Gastrointestinal Endoscopy Reporting System in Improving Report Quality
Recruiting NCT05009212 - Endoscopic Stricturotomy Versus Endoscopic Balloon Dilatation in Patients With Crohn's Disease and Symptomatic Small Bowel Stricture N/A